Cargando…

Assessing user preferences for design characteristics of oral dissolvable strips for pediatric HIV medication: a qualitative study

BACKGROUND: Current infant antiretroviral therapy formulations pose barriers to daily adherence due to complex weight-based dosing, conspicuous preparation, and poor palatability. These adherence barriers jeopardize adherence, making patients vulnerable to virologic failure, development of drug resi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wexler, Catherine, Maloba, May, Sliefert, Michala, Babu, Shadrack, Maosa, Nicodemus, Maliski, Edward, Nicolay, Zachary, Were, Frederick, Mbithi, Yvonne, Mugendi, George, Thomas, Gregory, Acharya, Harshdeep, Finocchario-Kessler, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580521/
https://www.ncbi.nlm.nih.gov/pubmed/37845699
http://dx.doi.org/10.1186/s12913-023-10078-6
_version_ 1785121958514393088
author Wexler, Catherine
Maloba, May
Sliefert, Michala
Babu, Shadrack
Maosa, Nicodemus
Maliski, Edward
Nicolay, Zachary
Were, Frederick
Mbithi, Yvonne
Mugendi, George
Thomas, Gregory
Acharya, Harshdeep
Finocchario-Kessler, Sarah
author_facet Wexler, Catherine
Maloba, May
Sliefert, Michala
Babu, Shadrack
Maosa, Nicodemus
Maliski, Edward
Nicolay, Zachary
Were, Frederick
Mbithi, Yvonne
Mugendi, George
Thomas, Gregory
Acharya, Harshdeep
Finocchario-Kessler, Sarah
author_sort Wexler, Catherine
collection PubMed
description BACKGROUND: Current infant antiretroviral therapy formulations pose barriers to daily adherence due to complex weight-based dosing, conspicuous preparation, and poor palatability. These adherence barriers jeopardize adherence, making patients vulnerable to virologic failure, development of drug resistance, and preventable mortality. Our team has previously established proof-of-principle for multi-drug oral dissolvable strips as alternative pediatric antiretroviral formulations with the potential to overcome these challenges and improve pediatric ART adherence and outcomes. The objective of this study was to assess caregiver and provider preferences for oral dissolvable strips and its packaging to inform its development. METHODS: Guided by concepts of user-centered design, we conducted key informant interviews with 30 HIV care providers and focus group discussions targeting caregivers of children < 10 years of age living with HIV at 3 Kenyan hospitals. Key informant interviews and focus group discussions were audio recorded, translated/transcribed verbatim, and hand coded for a-priori and emergent themes. RESULTS: A total of 30 providers and 72 caregivers (caring for 83 children, aged 5 months to 18 years) participated in the study. Caregivers and providers expressed a strong desire for an easier way to administer medication, especially among children too young to swallow tablets whole, and expressed enthusiasm around the idea of oral dissolvable strips. Key preferences included a pleasant taste; one strip per dose; small size with rapid dissolution; clear markings and instructions; and no special storage requirements. For packaging, stakeholders preferred individually wrapped strips within a dispenser. The individual packaging should be durable, waterproof, and easy to dispose of in communal spaces. They should also be easy to open, with clear indications where to open. The packaging holding the strips should be durable, re-usable, accommodating of various refill frequencies, and easy to use for children as young as 6. DISCUSSION: The concept of oral dissolvable strips was highly acceptable to caregivers of children living with HIV and HIV care providers. By engaging stakeholders in an iterative design process starting from the early phases of design and development, we will maximize the likelihood of developing a product that is acceptable to the caregiver and infant, therefore leading to sustainable adherence. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-023-10078-6.
format Online
Article
Text
id pubmed-10580521
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105805212023-10-18 Assessing user preferences for design characteristics of oral dissolvable strips for pediatric HIV medication: a qualitative study Wexler, Catherine Maloba, May Sliefert, Michala Babu, Shadrack Maosa, Nicodemus Maliski, Edward Nicolay, Zachary Were, Frederick Mbithi, Yvonne Mugendi, George Thomas, Gregory Acharya, Harshdeep Finocchario-Kessler, Sarah BMC Health Serv Res Research BACKGROUND: Current infant antiretroviral therapy formulations pose barriers to daily adherence due to complex weight-based dosing, conspicuous preparation, and poor palatability. These adherence barriers jeopardize adherence, making patients vulnerable to virologic failure, development of drug resistance, and preventable mortality. Our team has previously established proof-of-principle for multi-drug oral dissolvable strips as alternative pediatric antiretroviral formulations with the potential to overcome these challenges and improve pediatric ART adherence and outcomes. The objective of this study was to assess caregiver and provider preferences for oral dissolvable strips and its packaging to inform its development. METHODS: Guided by concepts of user-centered design, we conducted key informant interviews with 30 HIV care providers and focus group discussions targeting caregivers of children < 10 years of age living with HIV at 3 Kenyan hospitals. Key informant interviews and focus group discussions were audio recorded, translated/transcribed verbatim, and hand coded for a-priori and emergent themes. RESULTS: A total of 30 providers and 72 caregivers (caring for 83 children, aged 5 months to 18 years) participated in the study. Caregivers and providers expressed a strong desire for an easier way to administer medication, especially among children too young to swallow tablets whole, and expressed enthusiasm around the idea of oral dissolvable strips. Key preferences included a pleasant taste; one strip per dose; small size with rapid dissolution; clear markings and instructions; and no special storage requirements. For packaging, stakeholders preferred individually wrapped strips within a dispenser. The individual packaging should be durable, waterproof, and easy to dispose of in communal spaces. They should also be easy to open, with clear indications where to open. The packaging holding the strips should be durable, re-usable, accommodating of various refill frequencies, and easy to use for children as young as 6. DISCUSSION: The concept of oral dissolvable strips was highly acceptable to caregivers of children living with HIV and HIV care providers. By engaging stakeholders in an iterative design process starting from the early phases of design and development, we will maximize the likelihood of developing a product that is acceptable to the caregiver and infant, therefore leading to sustainable adherence. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-023-10078-6. BioMed Central 2023-10-16 /pmc/articles/PMC10580521/ /pubmed/37845699 http://dx.doi.org/10.1186/s12913-023-10078-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wexler, Catherine
Maloba, May
Sliefert, Michala
Babu, Shadrack
Maosa, Nicodemus
Maliski, Edward
Nicolay, Zachary
Were, Frederick
Mbithi, Yvonne
Mugendi, George
Thomas, Gregory
Acharya, Harshdeep
Finocchario-Kessler, Sarah
Assessing user preferences for design characteristics of oral dissolvable strips for pediatric HIV medication: a qualitative study
title Assessing user preferences for design characteristics of oral dissolvable strips for pediatric HIV medication: a qualitative study
title_full Assessing user preferences for design characteristics of oral dissolvable strips for pediatric HIV medication: a qualitative study
title_fullStr Assessing user preferences for design characteristics of oral dissolvable strips for pediatric HIV medication: a qualitative study
title_full_unstemmed Assessing user preferences for design characteristics of oral dissolvable strips for pediatric HIV medication: a qualitative study
title_short Assessing user preferences for design characteristics of oral dissolvable strips for pediatric HIV medication: a qualitative study
title_sort assessing user preferences for design characteristics of oral dissolvable strips for pediatric hiv medication: a qualitative study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580521/
https://www.ncbi.nlm.nih.gov/pubmed/37845699
http://dx.doi.org/10.1186/s12913-023-10078-6
work_keys_str_mv AT wexlercatherine assessinguserpreferencesfordesigncharacteristicsoforaldissolvablestripsforpediatrichivmedicationaqualitativestudy
AT malobamay assessinguserpreferencesfordesigncharacteristicsoforaldissolvablestripsforpediatrichivmedicationaqualitativestudy
AT sliefertmichala assessinguserpreferencesfordesigncharacteristicsoforaldissolvablestripsforpediatrichivmedicationaqualitativestudy
AT babushadrack assessinguserpreferencesfordesigncharacteristicsoforaldissolvablestripsforpediatrichivmedicationaqualitativestudy
AT maosanicodemus assessinguserpreferencesfordesigncharacteristicsoforaldissolvablestripsforpediatrichivmedicationaqualitativestudy
AT maliskiedward assessinguserpreferencesfordesigncharacteristicsoforaldissolvablestripsforpediatrichivmedicationaqualitativestudy
AT nicolayzachary assessinguserpreferencesfordesigncharacteristicsoforaldissolvablestripsforpediatrichivmedicationaqualitativestudy
AT werefrederick assessinguserpreferencesfordesigncharacteristicsoforaldissolvablestripsforpediatrichivmedicationaqualitativestudy
AT mbithiyvonne assessinguserpreferencesfordesigncharacteristicsoforaldissolvablestripsforpediatrichivmedicationaqualitativestudy
AT mugendigeorge assessinguserpreferencesfordesigncharacteristicsoforaldissolvablestripsforpediatrichivmedicationaqualitativestudy
AT thomasgregory assessinguserpreferencesfordesigncharacteristicsoforaldissolvablestripsforpediatrichivmedicationaqualitativestudy
AT acharyaharshdeep assessinguserpreferencesfordesigncharacteristicsoforaldissolvablestripsforpediatrichivmedicationaqualitativestudy
AT finocchariokesslersarah assessinguserpreferencesfordesigncharacteristicsoforaldissolvablestripsforpediatrichivmedicationaqualitativestudy